Replimune Group, Inc. (7R8)
Market Open
23 Oct, 07:57 PM
XSTU 
€
10. 20
-0.43
-4.0452%
€
- Market Cap
- P/E Ratio
- Div Yield
200 Volume
-3.52 Eps
€ 10.63
Previous Close Want to track 7R8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
7R8 Earnings Reports FAQ
What is the earnings per share (EPS) for 7R8?
The current EPS is -3.52.
What is the company's earnings growth rate?
Replimune Group, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Replimune Group, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Replimune Group, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 7R8 at this time, as Replimune Group, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
